Coccolithophores are single-celled marine phytoplankton, which produce intricate calcium carbonate platelets or ‘coccoliths’. Emiliania huxleyi is the most abundant and widespread coccolithophore, and is one of the most productive calcifying species on earth, playing a key role in global carbon, carbonate and sulphur cycles. Despite much research into coccolithophore biology, the underlying function of their coccoliths is still unknown. The main aim of the research reported in this thesis was to examine the impact of calcification on metabolism in coccolithophores. Calcification is a significant global process, so it is important to discover what effect it has on the metabolism of cells. The major metabolites each have different costs and benefits to the cell, which will vary depending on the habitat and environmental conditions the cell is in. By comparing the metabolite profiles of different strains, including calcifying, non-calcifying, haploid and diploid cells, differences in metabolite composition and potential patterns related to cell type were investigated. Low molecular weight (LMW) metabolites were characterised using a combination of metabolomic techniques. In agreement with previous research, dimethylsulphoniopropionate (DMSP) was the most abundant compound, followed by mannitol and glycine betaine (GBT). Less abundant sugars, polyols and amino acids were also identified. Environmental factors were manipulated to investigate how the principal metabolites were affected by salinity, different light intensities and nutrient (phosphate and nitrate) limitation. The data revealed a striking difference between haploid and diploid cells of the same strain, with the haploid containing lower concentrations of most of the major metabolites. Thus it is proposed that haploid cells have a different osmoregulatory strategy from the diploid cells. A negative correlation was found between DMSP and mannitol, suggesting that mannitol has a dual function, not only as a major storage compound but also as a principal compatible solute. Untargeted metabolite profiling is becoming a popular tool to investigate phenotypes and varying environmental conditions. LC-ESI-QTOF-MS/MS analyses of a wide range of metabolites showed that it is an effective method to identify differences and similarities between E. huxleyi strains grown in different conditions. Strain and growth phase appear to be the more important factors in differentiating metabolite profiles. Surprisingly there were no obvious metabolite profiling differences between calcifying and non-calcifying cells. Untargeted analysis can, however, be used to identify the compounds that did display differences, and which may be important biomarkers, so warrant further investigation. A range of metabolite profiling techniques highlighted important differences between strains, which will hopefully lead onto further research into the metabolome of E. huxleyi, and the unravelling of important metabolic pathways. There has been little research into the LMW metabolites of E. huxleyi, and especially comparisons between strains. Thus the use of metabolomics is a novel way to investigate the difference between cell types and the possible functions of calcification.

Einleitung: Mit der vorliegenden Studie wurden zum ersten Mal beim Menschen die Auswirkungen von Dehydration (Dehy) und anschließender Rehydratation (Rehy) auf cerebrale volumenregulatorische Metabolite (myo-Inosit (mI), N-Azetylaspartat+N-Azetylaspartylglutamat (tNAA), Kreatin (Cr), Glyzerophosphocholin+Phosphocholin (Cho) und Glutamat+Glutamin (Glx)) sowie auf Flüssigkeitsverschiebungen untersucht. Methoden: 14 Radsportler (26.6 (22.7/29.8) Jahre, Median und 25./75. Perzentile) wurden mittels 1H-Spektroskopie (1H-MRS) in der okzipitoparietalen grauen Substanz (GM) und parietalen weißen Substanz rechts (WMR) und links (WML) untersucht (GE Signa Horizon 3T94; PRESS: TE 30ms, TR 6000ms, VOI 8ml). Die Messungen erfolgten vor, direkt nach Dehy und nach Rehy (180min, Zufuhr von 150\% der verlorenen Körpermasse (KM)). Zusätzlich wurde durch T2-Relaxationsmessungen der Atrophieindex alpha (Verhältnis cerebrales Gewebewasser (HW) zu Liquor (CSF)) bestimmt. Resultate: Die KM der Probanden reduzierte sich durch Dehy um 3.7 (3.4/4.1)% und stieg durch Rehy wieder um 4.5 (3.7/5.3)% an (Wilcoxon: p / Introduction: In the present study the influence of Dehy on cerebral volume regulatory metabolites (myo-Inositol (mI), N-Acetyl-aspartata+N-Acetyl-aspartyl-glutamate (tNAA), Creatine (Cr), Glycerophosphocholine+Phosphocholine (Cho) and Glutamate+Glutamine (Glx)) and fluid shifts has been investigated for the first time in humans. Methods: 14 cyclists (26.6 (22.7/29.8) y, median and 25./75. percentile) have been examined with proton NMR spectroscopy in the occipito-parietal gray matter (GM) and the right (WMR) and left (WML) parietal with matter (GE Signa Horizon 3T94; PRESS: TE 30ms, TR 6000ms, VOI 8ml). Spectra were acquired before, immediately after Dehy and after rehydration (Rehy). Rehy took place during 180min and 150% of lost body weight (BW) was substituted. Additionally the atrophy index alpha (ratio between cerebral water and liquor) was assessed (T2 signal decay as a function of echo time). Results: BW of volunteers has been decreased 3.7 (3.4/4.1)% after Dehy and increased 4.5 (3.7/5.3)% after Rehy (Wilcoxon: p

Diese Schrift faßt in zwei Abschnitten eigene Beiträge zur Einführung der lokalisierten Magnetresonanzspektroskopie (MRS) und der funktionellen Magnetresonanztomografie (fMRT) in die diagnostische Medizin zusammen. Im ersten Teil wird beschrieben, wie die biochemischen Metabolite N-Azetylaspartat, Kreatin und Phosphokreatin, cholin-enthaltende Verbindungen und Laktat durch die Einführung der stimulierten Echo-Akquisitionsmethode (STEAM) als Lokalisationstechnik in die diagnostische Magnetresonanzspektroskopie in definierten Hirnregionen gesunder Versuchspersonen nichtinvasiv zugänglich gemacht und erstmals in Form von In-vivo-Konzentrationen quantifiziert werden konnten. Daraufhin wird gezeigt, wie die Weiterentwicklung der robusten STEAM-Technik zu kurzen Echozeiten das Signal-zu-Rauschverhältnis und damit die Messung kleinerer Untersuchungsvolumina erheblich verbesserte. Zudem wurde dadurch die Erkennung und Quantifizierung weiterer Metabolite wie z. B. des myo- und scyllo-Inosits, des Glutamats und Glutamins, des N-Azetylaspartylglutamats und der Glukose ermöglicht. Diese Methode setzte damit zusammen mit der verwendeten linearen Kombinationsmethode (LCModel) zur Konzentrationsbestimmung den spektralen Qualitätsstandard des gesamten letzten Jahrzehnts. Ferner werden die parallelen Pionierarbeiten zu Hirnerkrankungen fokaler und generalisierter Art beleuchtet. Diese Anwendungen der lokalisierten STEAM-Protonenspektroskopie in Einzelvolumentechnik zur Messung umschriebener Prozesse umfassen zerebrale Tumore und Infarkte, Plaques der multiplen Sklerose sowie andere entzündliche und degenerative Läsionen. Auch die lokalisierte STEAM-Phosphorspektroskopie und nichtzerebrale Anwendungen wie die lokalisierte Protonenspektroskopie von Faserbündeln des Skelettmuskels und der Niere bauen weitgehend auf diesem Fortschritt in der Methode auf. Zusätzlich werden Anwendungen bei generalisierten Erkrankungen gestreift, speziell angeborenen Stoffwechselerkrankungen des Kindesalters wie mitochondrialen und lysosomalen Defekten, Stoffwechselentgleisungen bei Diabetes mellitus und Leberzirrhose, psychiatrischen Erkrankungen wie der Alzheimer-Demenz. Die weitere Verbreitung dieser Erkenntnisse in die klinische Diagnostik wird entscheidend von der Beachtung des hier eingeführten Qualitätsmaßstabs und der darauf aufbauenden absoluten Metabolitquantifizierung abhängen. Der zweite Teil dieser Arbeit faßt ausgehend von funktionellen protonenspektroskopischen Untersuchungen des visuellen Kortex bei photischer Aktivierung Fortschritte zusammen, die bei der Entwicklung und Anwendung der suszeptibilitätsempfindlichen MR-Tomografie zur Messung physiologischer Hirnaktivierung mit dem Modell der visuellen Stimulation erzielt wurden. Während die Belastung des Energiestoffwechsels im angeregten striatären Kortex anhand abgesunkener Gewebespiegel von Glukose und angestiegener Laktatkonzentrationen mithilfe der zeitaufgelösten Spektroskopie beobachtet werden konnte, gelang die Demarkierung der Ausdehnung der Hirngewebeaktivierung mithilfe der T2*-gewichteten FLASH-MRT, die begleitende Verminderungen des paramagnetischen Desoxyhämoglobins im funktionell aktiven Gewebe mit Anstiegen der Bildsignalintensität wiedergibt. Schließlich werden Untersuchungen beschrieben, die die Empfindlichkeit dieses endogenen, sauerstoffspiegelabhängigen Suszeptibilitätskontrastes für die Wirkung verschiedener Medikamente bzw. pharmakologischer Stimulantien zeigen, die direkt oder indirekt über bestimmte vaskuläre Rezeptoren wirken. Diese Untersuchungen befördern wiederum ein neues Gebiet der Bildgebung, die pharmakologische MRT. / This work has two main parts that summarize pioneering contributions to localized magnetic resonance spectroscopy (MRS), functional magnetic resonance tomography (fMRI), and the introduction of these modalities into diagnostic medicine. First, it is described how biochemical metabolites such as the intracellular pools of N-acetylaspartate, creatine and phosphocreatine, choline-containing compounds, and lactate have been made accessible to noninvasive detection and to the quantification of their respective concentrations in vivo in defined cerebral regions of healthy subjects by utilizing the stimulated echo-acquisition mode (STEAM) localization technique. Then it is shown that further development of the robust STEAM technique to short echo times not only increased the signal-to-noise of the measurement, thereby providing access to smaller volumes-of-interest, but also allowed for the detection and quantification of additional metabolites such as myo- and scyllo-inositol, glutamate, glutamine, N-acetylaspartylglutamate, and glucose. Thus, together with the adoption of the linear combination method (LCModel) for concentration calculation, this method has set the standard for spectroscopic state-of-the-art in the field well over the last decade. Moreover, pioneering achievements have been highlighted with regard to applications in brain diseases of focal and generalized nature. Pertinent applications of localized single-volume STEAM proton spectroscopy to circumscribed processes include cerebral tumors, cerebral infarction, multiple sclerosis plaques, and other inflammatory and degenerative lesions. Also localized STEAM phosphorus spectroscopy and non-cerebral applications including localized proton spectroscopy of skeletal muscle and kidney largely depend on the short-echo time STEAM technique. In addition, applications in generalized disorders have been explored, which include inborn errors of metabolism in childhood, such as mitochondrial and lysosomal defects, metabolic disturbances in diabetes mellitus and liver cirrhosis, and psychiatric diseases such as Alzheimer's dementia. The further utilization of these novel methods in clinical diagnostics will heavily depend on quality measures and the mastering of a true quantification procedure as demonstrated. Second, this work summarizes achievements made in developing and applying both proton MR spectroscopy and susceptibility-sensitized MR imaging to measure physiologic brain activation using visual stimulation as a model. Whereas metabolic stress, brought upon the bioenergetic steady state in the responding striate cortex, was detected by decreased parenchymal glucose and increased lactate using time-resolved spectroscopy, mapping the extent of parenchymal activation was found to be possible by increases of image intensity in T2*-weighted FLASH MRI made sensitive to concomitant decreases of paramagnetic deoxyhemoglobin in the functionally active tissue. Finally, studies are described, which show the sensitivity of this endogenous, susceptibility-sensitive contrast, now generally known as BOLD effect, to various drugs or pharmacologic stimuli acting either directly or indirectly on vascular receptors. These latter studies open up again a new field of imaging, dubbed pharmacologic MRI.